FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993831043> ?p ?o ?g. }

• W1993831043 endingPage "923" @default.
• W1993831043 startingPage "916" @default.
• W1993831043 abstract "Abstract Rasagiline ( N ‐propargyl‐1( R )‐aminoindan) mesylate is a potent, selective, and irreversible monoamine oxidase‐B inhibitor. This study was designed to evaluate the safety, tolerability, and preliminary efficacy of rasagiline monotherapy in early Parkinson's disease (PD) patients not receiving levodopa. The study was performed as a multicenter, parallel‐group, double‐blind, randomized, placebo‐controlled, 10‐week study. Fifty‐six PD patients were randomly assigned to rasagiline mesylate 1, 2, or 4 mg once daily, or placebo. A 3‐week dose‐escalation period was followed by a 7‐week maintenance phase. At week 10, the mean (±SE) changes from baseline in total Unified Parkinson's Disease Rating Scale (UPDRS) score were −1.8 (±1.3), −3.6 (±1.7), −3.6 (±1.2), and −0.5 (±0.8) in the rasagiline 1, 2, and 4 mg/day and placebo groups, respectively. Analysis of responders showed that 28% of patients (12 of 43) receiving rasagiline had an improvement in total UPDRS score of greater than 30%, compared with none of the patients receiving placebo ( P < 0.05, Fisher's exact test). The frequency and types of adverse events reported by rasagiline‐treated and placebo‐treated patients were similar. These results suggest that rasagiline monotherapy is well tolerated and efficacious in early PD. © 2004 Movement Disorder Society" @default.
• W1993831043 created "2016-06-24" @default.
• W1993831043 creator A5017122855 @default.
• W1993831043 creator A5022553846 @default.
• W1993831043 creator A5067906113 @default.
• W1993831043 creator A5072390302 @default.
• W1993831043 creator A5080057970 @default.
• W1993831043 creator A5088654646 @default.
• W1993831043 creator A5091194111 @default.
• W1993831043 date "2004-04-27" @default.
• W1993831043 modified "2023-10-13" @default.
• W1993831043 title "Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients" @default.
• W1993831043 cites W1563482732 @default.
• W1993831043 cites W17131581 @default.
• W1993831043 cites W1964771081 @default.
• W1993831043 cites W1970679628 @default.
• W1993831043 cites W1976952682 @default.
• W1993831043 cites W1982916435 @default.
• W1993831043 cites W1990627055 @default.
• W1993831043 cites W1993964261 @default.
• W1993831043 cites W2004436319 @default.
• W1993831043 cites W2010170013 @default.
• W1993831043 cites W2016833889 @default.
• W1993831043 cites W2039821298 @default.
• W1993831043 cites W2043951579 @default.
• W1993831043 cites W2044368552 @default.
• W1993831043 cites W2045729751 @default.
• W1993831043 cites W2058495554 @default.
• W1993831043 cites W2066721457 @default.
• W1993831043 cites W2072394501 @default.
• W1993831043 cites W2082953267 @default.
• W1993831043 cites W2085307991 @default.
• W1993831043 cites W2091818830 @default.
• W1993831043 cites W2092094344 @default.
• W1993831043 cites W2137669059 @default.
• W1993831043 cites W2278392995 @default.
• W1993831043 cites W2302113434 @default.
• W1993831043 cites W2595176684 @default.
• W1993831043 cites W969268145 @default.
• W1993831043 doi "https://doi.org/10.1002/mds.20145" @default.
• W1993831043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15300656" @default.
• W1993831043 hasPublicationYear "2004" @default.
• W1993831043 type Work @default.
• W1993831043 sameAs 1993831043 @default.
• W1993831043 citedByCount "104" @default.
• W1993831043 countsByYear W19938310432012 @default.
• W1993831043 countsByYear W19938310432013 @default.
• W1993831043 countsByYear W19938310432014 @default.
• W1993831043 countsByYear W19938310432015 @default.
• W1993831043 countsByYear W19938310432016 @default.
• W1993831043 countsByYear W19938310432017 @default.
• W1993831043 countsByYear W19938310432018 @default.
• W1993831043 countsByYear W19938310432019 @default.
• W1993831043 countsByYear W19938310432020 @default.
• W1993831043 countsByYear W19938310432021 @default.
• W1993831043 countsByYear W19938310432022 @default.
• W1993831043 countsByYear W19938310432023 @default.
• W1993831043 crossrefType "journal-article" @default.
• W1993831043 hasAuthorship W1993831043A5017122855 @default.
• W1993831043 hasAuthorship W1993831043A5022553846 @default.
• W1993831043 hasAuthorship W1993831043A5067906113 @default.
• W1993831043 hasAuthorship W1993831043A5072390302 @default.
• W1993831043 hasAuthorship W1993831043A5080057970 @default.
• W1993831043 hasAuthorship W1993831043A5088654646 @default.
• W1993831043 hasAuthorship W1993831043A5091194111 @default.
• W1993831043 hasConcept C126322002 @default.
• W1993831043 hasConcept C142724271 @default.
• W1993831043 hasConcept C197934379 @default.
• W1993831043 hasConcept C204787440 @default.
• W1993831043 hasConcept C27081682 @default.
• W1993831043 hasConcept C2778375690 @default.
• W1993831043 hasConcept C2779134260 @default.
• W1993831043 hasConcept C2779734285 @default.
• W1993831043 hasConcept C2780304432 @default.
• W1993831043 hasConcept C2781249495 @default.
• W1993831043 hasConcept C71924100 @default.
• W1993831043 hasConceptScore W1993831043C126322002 @default.
• W1993831043 hasConceptScore W1993831043C142724271 @default.
• W1993831043 hasConceptScore W1993831043C197934379 @default.
• W1993831043 hasConceptScore W1993831043C204787440 @default.
• W1993831043 hasConceptScore W1993831043C27081682 @default.
• W1993831043 hasConceptScore W1993831043C2778375690 @default.
• W1993831043 hasConceptScore W1993831043C2779134260 @default.
• W1993831043 hasConceptScore W1993831043C2779734285 @default.
• W1993831043 hasConceptScore W1993831043C2780304432 @default.
• W1993831043 hasConceptScore W1993831043C2781249495 @default.
• W1993831043 hasConceptScore W1993831043C71924100 @default.
• W1993831043 hasIssue "8" @default.
• W1993831043 hasLocation W19938310431 @default.
• W1993831043 hasLocation W19938310432 @default.
• W1993831043 hasOpenAccess W1993831043 @default.
• W1993831043 hasPrimaryLocation W19938310431 @default.
• W1993831043 hasRelatedWork W1919842320 @default.
• W1993831043 hasRelatedWork W1980588181 @default.
• W1993831043 hasRelatedWork W2013803461 @default.
• W1993831043 hasRelatedWork W2029020730 @default.
• W1993831043 hasRelatedWork W2044381184 @default.
• W1993831043 hasRelatedWork W2072325060 @default.

• next